Arecor Therapeutics takes existing pharma products and reformulates them for new uses or to make them more effective. This reduces the risk, compared with developing completely new drugs.
Arecor has secured partnerships for some products, but the insulin products for diabetes are being developed to the phase II clinical trial stage and then a partner will be sought.
Any of these products could address significant markets so if one becomes a commercial product, particularly an insulin product, that could help to underpin the valuation of the company. The diabetes insulin products are sti...
